Childhood, adolescent and young adult cancer survivors may develop treatment-induced hypothalamic-pituitary dysfunction. Because of this risk, at-risk survivors may benefit from surveillance of hypothalamic-pituitary dysfunction surveillance. This guideline describes the groups at risk and the surveillance recommended for this group
Quality of LifeAllGuidelines
IGHG Guideline on Hypothalamic-Pituitary Dysfunction
Recommendations for surveillance for hypothalamic-pituitary dysfunction in survivors
Year:2021
Discussion & Questions
Note: Comments are for discussion and clarification only. For medical advice, please consult with a healthcare professional.
Leave a Comment
No comments yet
Be the first to share your thoughts!
Related Resources
Improving the Care of Children in Europe With Rare Cancer
The European Society for Paediatric Oncology together with Coordinators for the PARTNER Project and ERN PaedCan highligh...
Quality of LifeAll
Read
Inequality of Care of Adult Cancer Survivor in Sweden Depending on Geographical Location
An interview with Professor Hans Hägglund, whom until recently acted as head physician and operations manager at Uppsala...
SurvivorshipAll
Read
The Childhood Cancer Biobank in Sweden That Helps Improve Understanding of Tumours
Interview with Monica Nistér, senior professor of pathology and former unit manager of Barntumörbanken as well as Johann...
ScienceAll
Read